Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biohaven Pharmaceuticals, Inc.

Clinical trials sponsored by Biohaven Pharmaceuticals, Inc., explained in plain language.

Biohaven Pharmaceuticals, Inc. BHVN NYSE

A biopharmaceutical company focused on neuroscience and immunology.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 4 Terminated 1

New hope for SCA patients: expanded access to investigational drug troriluzole

Disease control AVAILABLE

This expanded access program offers the investigational drug troriluzole to people with spinocerebellar ataxia (SCA), a rare brain disorder that affects movement and coordination. Participants take a daily pill. The goal is to provide access to the drug while it is still being st…

Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC